Astrego is accelerating product development activities in Uppsala.
Astrego’s disruptive technology makes it possible to capture individual bacterial cells from complex samples and measure their growth rate in real-time. This enables the fastest possible Antibiotic Susceptibility Test (AST).
Products targeting a wide range of microbiological applications, designed to enable evidence-based prescription of antibiotics and help reduce the spread of antimicrobial resistance (AMR).
Astrego Diagnostics is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. Our team combines multidisciplinary scientific excellence with seasoned diagnostic industry management.